Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Hauts-de-France, specialists in sustainable transport

Created in 2009, Transalley (Sustainable and Innovative Mobility Technology Park) has not stopped developing. Review of a cluster with international ambition and its future facilities for supporting...

NTN is investing €14m in Hauts-de-France up to 2021

Japan's NTN group is planning considerable investments in Hauts-de-France: €4 million between 2018 and 2020, 10 million up to 2021 (and then 36 million up to 2031). These investments aim to modernise the...

All news